LIQUIDITY MANAGEMENT OF SUN PHARMA : AN EVIDENCE FROM MOTAAL’S COMPREHENSIVE TEST

  • Unique Paper ID: 191261
  • Volume: 12
  • Issue: 8
  • PageNo: 5790-5794
  • Abstract:
  • This study aims to evaluate the liquidity management practices of Sun Pharmaceutical Industries Ltd. (Sun Pharma), one of India's largest pharmaceutical companies, using Motaal’s Comprehensive Test. Liquidity management is a crucial aspect of financial health for any corporation, and pharmaceutical companies, given their substantial investment in research and development, inventory, and distribution, require effective strategies to manage their liquidity. The paper utilizes Motaal's Comprehensive Test, a widely recognized analytical method, to assess the company’s liquidity position over a specific period. Key financial ratios such as the current ratio, quick ratio, and working capital turnover are analysed to determine how efficiently Sun Pharma handles its short-term obligations. The findings indicate that Sun Pharma has maintained a healthy liquidity position, with a balanced approach to managing both its short-term liabilities and long-term investments. Furthermore, the study highlights the impact of macroeconomic factors, industry trends, and Sun Pharma's internal strategies on its liquidity performance. The results suggest that the company's liquidity management strategy is well-structured and aligned with its operational goals, providing a foundation for sustainable growth. The paper concludes with recommendations on improving liquidity management practices, considering the dynamic nature of the pharmaceutical industry.

Copyright & License

Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{191261,
        author = {Dr.A.SENGOTTAIYAN and MAKIREDDI KALPANA},
        title = {LIQUIDITY MANAGEMENT OF SUN PHARMA : AN EVIDENCE FROM MOTAAL’S COMPREHENSIVE TEST},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {12},
        number = {8},
        pages = {5790-5794},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=191261},
        abstract = {This study aims to evaluate the liquidity management practices of Sun Pharmaceutical Industries Ltd. (Sun Pharma), one of India's largest pharmaceutical companies, using Motaal’s Comprehensive Test. Liquidity management is a crucial aspect of financial health for any corporation, and pharmaceutical companies, given their substantial investment in research and development, inventory, and distribution, require effective strategies to manage their liquidity. The paper utilizes Motaal's Comprehensive Test, a widely recognized analytical method, to assess the company’s liquidity position over a specific period. Key financial ratios such as the current ratio, quick ratio, and working capital turnover are analysed to determine how efficiently Sun Pharma handles its short-term obligations. The findings indicate that Sun Pharma has maintained a healthy liquidity position, with a balanced approach to managing both its short-term liabilities and long-term investments. Furthermore, the study highlights the impact of macroeconomic factors, industry trends, and Sun Pharma's internal strategies on its liquidity performance. The results suggest that the company's liquidity management strategy is well-structured and aligned with its operational goals, providing a foundation for sustainable growth. The paper concludes with recommendations on improving liquidity management practices, considering the dynamic nature of the pharmaceutical industry.},
        keywords = {Pharmaceutical company, Sun Pharma, liquidity management, Motaal’s Comprehensive Test.},
        month = {January},
        }

Cite This Article

  • ISSN: 2349-6002
  • Volume: 12
  • Issue: 8
  • PageNo: 5790-5794

LIQUIDITY MANAGEMENT OF SUN PHARMA : AN EVIDENCE FROM MOTAAL’S COMPREHENSIVE TEST

Related Articles